Becton, Dickinson Current Ratio 2006-2018 | BDX

Historical current ratio values for Becton, Dickinson (BDX) over the last 10 years.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.028B $12.093B
Becton, Dickinson & Company is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues.
Stock Name Country Market Cap PE Ratio
Align Technology (ALGN) United States $30.087B 88.95
McKesson (MCK) United States $26.816B 10.51
Laboratory Of America Holdings (LH) United States $19.049B 18.40
AmerisourceBergen (ABC) United States $18.617B 13.55
Cardinal Health (CAH) United States $15.161B 9.57
Cooper (COO) United States $12.206B 22.72
Henry Schein (HSIC) United States $11.600B 20.55
DENTSPLY SIRONA (XRAY) United States $10.242B 17.19
West Pharmaceutical Services (WST) United States $7.329B 40.82
Merit Medical Systems (MMSI) United States $2.813B 42.27
Patterson (PDCO) United States $2.239B 14.07
CONMED (CNMD) United States $2.059B 35.82
STAAR Surgical (STAA) United States $1.411B 484.29
Atrion (ATRI) United States $1.167B 33.32
Invacare (IVC) United States $0.695B 0.00
Endologix (ELGX) United States $0.445B 0.00
Antares Pharma (ATRS) United States $0.436B 0.00
Lifevantage (LFVN) United States $0.140B 29.06
Aceto (ACET) United States $0.099B 4.04
Pro-Dex (PDEX) United States $0.029B 12.95
Biolase (BIOL) United States $0.028B 0.00